Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
58.84
+5.18 (9.64%)
At close: May 21, 2026, 4:00 PM EDT
58.01
-0.83 (-1.40%)
Pre-market: May 22, 2026, 7:07 AM EDT
Twist Bioscience Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Twist Bioscience stock has a consensus rating of "Strong Buy" and an average price target of $63.33. The average 1-year stock price forecast is 7.64% higher than the current stock price, while the lowest is $36 (-38.81%) and the highest is $75 (+27.48%).
Price Target: $63.33 (+7.64%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Twist Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Buy | 5 | 5 | 5 | 4 | 4 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $70 | Hold → Buy | Upgrades | $70 | +18.98% | May 5, 2026 |
| Barclays | Barclays | Buy Maintains $55 → $65 | Buy | Maintains | $55 → $65 | +10.48% | May 5, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $55 → $60 | Strong Buy | Maintains | $55 → $60 | +1.98% | May 5, 2026 |
| Baird | Baird | Buy Maintains $50 → $65 | Buy | Maintains | $50 → $65 | +10.48% | May 5, 2026 |
| Barclays | Barclays | Buy Maintains $50 → $55 | Buy | Maintains | $50 → $55 | -6.52% | Apr 14, 2026 |
Financial Forecast
Revenue This Year
454.36M
from 376.57M
Increased by 20.66%
Revenue Next Year
523.87M
from 454.36M
Increased by 15.30%
EPS This Year
-1.88
from -1.30
EPS Next Year
-1.42
from -1.88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 469.1M | 548.1M | |||
| Avg | 454.4M | 523.9M | |||
| Low | 430.5M | 485.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 24.6% | 20.6% | |||
| Avg | 20.7% | 15.3% | |||
| Low | 14.3% | 6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.92 | -1.01 | |
| Avg | -1.88 | -1.42 | |
| Low | -2.13 | -1.75 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.